Catalyst Wire Dossier Catalyst Wire Dossier

Levocetirizine dihydrochloride (generic)

Levocetirizine dihydrochloride · Glenmark Pharmaceuticals Inc., USA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Levocetirizine dihydrochloride (generic), covering 2015-11-25 to 2015-11-25. Get the full timeline:

Most recent: FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

See pricing